Information Journal Paper
APA:
Copy. (2020). Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells. Cells, 9(4), 877-879. SID. https://sid.ir/paper/983463/en
Vancouver:
Copy. Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells. Cells[Internet]. 2020;9(4):877-879. Available from: https://sid.ir/paper/983463/en
IEEE:
Copy, “Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells,” Cells, vol. 9, no. 4, pp. 877–879, 2020, [Online]. Available: https://sid.ir/paper/983463/en